Publications
“Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever”, Journal of Antimicrobial and Chemotherapy, vol. 40, no. 1, pp. 91-8, 1997.
, “Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria”, Am J Trop Med Hyg, vol. 87, no. 1, pp. 35-40, 2012.
, “Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo”, PLoS Negl Trop Dis, vol. 9, no. 3, p. e0003595, 2015.
, “Artesunate combinations for treatment of malaria: meta-analysis”, Lancet, vol. 363, no. 9402. pp. 9-17, 2004.
, “Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosing”, Antimicrobial agents and chemotherapy, pp. AAC. 02193-17, 2018.
, “The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria”, Malar J, vol. 8, p. 207, 2009.
, “Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients”, Clin Transl Immunology, vol. 8, no. 7, p. e1066, 2019.
, “Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening”, International Journal of Neonatal Screening, vol. 4, p. 34, 2018.
, “Geographical Distribution of Selected and Putatively Neutral SNPs in Southeast Asian Malaria Parasites”, MOL BIOL EVOL, vol. 22, no. 12, pp. 2362-2374, 2005.
, “Inferred relatedness and heritability in malaria parasites”, Proc Biol Sci, 2010.
, “Microsatellite markers reveal a spectrum of population structures in the malaria parasite plasmodium falciparum”, Molecular Biology and Evolution, vol. 17, no. 10, pp. 1467-82, 2000.
, “Are Transporter Genes Other than the Chloroquine Resistance Locus (pfcrt) and Multidrug Resistance Gene (pfmdr) Associated with Antimalarial Drug Resistance?”, Antimicrob Agents Chemother, vol. 49, no. 6. pp. 2180-2188, 2005.
, “Population Parameters Underlying an Ongoing Soft Sweep in Southeast Asian Malaria Parasites”, Mol Biol Evol, vol. 34, no. 1, pp. 131-144, 2017.
, “The suitability of laboratory-bred Anopheles cracens for the production of Plasmodium vivax sporozoites”, Malar J, vol. 14, p. 312, 2015.
, “A Small Amount of Fat Does Not Affect Piperaquine Exposure in Patients with Malaria”, Antimicrob. Agents Chemother., vol. 55, no. 9, pp. 3971-3976, 2011.
, “Open-source discovery of chemical leads for next-generation chemoprotective antimalarials”, ScienceScience, vol. 362, 2018.
, “A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria”, Clinical Infectious Diseases, vol. 41, no. 4, pp. 425-432, 2005.
, “In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003”, Trop Med Int Health, vol. 11, no. 12, pp. 1898-9; author reply 1899, 2006.
, “Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, 2010.
, “Malaria”, Travel Med Infect Dis, vol. 4, no. 3-4. pp. 159-173, 2006.
, “Malaria”, The Lancet, vol. 391, pp. 1608-1621, 2018.
, “Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria”, Trop Med Int Health, vol. 12, no. 2, pp. 201-8, 2007.
, “Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity”, J Infect Dis, vol. 220, no. 1, pp. 100-104, 2019.
, “Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 50, no. 7, pp. 2281-5, 2006.
, “Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries”, Trop Med Int Health, vol. 16, no. 9, pp. 1167-1179, 2011.
, “Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand”, Journal of Infectious Diseases, vol. 190, no. 10, pp. 1773-82, 2004.
, “How much fat is necessary to optimize lumefantrine oral bioavailability?”, Trop Med Int Health, vol. 12, no. 2. pp. 195-200, 2007.
, “Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria”, Malar J, vol. 8, p. 241, 2009.
, “Artemisinin-based combinations”, Curr Opin Infect Dis, vol. 18, no. 6, pp. 531-6, 2005.
, “Spread of artemisinin resistance in Plasmodium falciparum malaria”, N Engl J Med, vol. 371, no. 5, pp. 411-23, 2014.
, “An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand”, Trop Med Int Health, vol. 11, no. 11, pp. 1653-60, 2006.
, “Adolescents’ perceptions and experiences of pregnancy in refugee and migrant communities on the Thailand-Myanmar border: a qualitative study”, Reproductive health, vol. 15, no. 1, p. 83, 2018.
, “Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study”, J Infect Dis, vol. 216, no. 6, pp. 723-731, 2017.
, “Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort”, Proc Natl Acad Sci U S A, vol. 114, no. 13, pp. 3515-3520, 2017.
, “Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics”, Nat CommunNat Commun, vol. 9, p. 2585, 2018.
, “Genomic analysis of Plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms”, J Infect Dis, 2019.
, “Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing”, PLoS ONE, vol. 8, no. 1, p. e53160, 2013.
, “A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes”, Wellcome Open Res, vol. 1, p. 4, 2016.
, “Genomic analysis reveals a common breakpoint in amplifications of the Plasmodium vivax multidrug resistance 1 locus in Thailand”, J Infect Dis, 2016.
, “Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial”, The American journal of tropical medicine and hygiene, vol. 97, no. 6, pp. 1782 - 1787, 2017.
, “Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study”, PARASITOLOGY, vol. 110, no. Suppl. pp. S25-36, 1995.
, “Asian G6PD-Mahidol reticulocytes sustain normal Plasmodium vivax development”, J Infect Dis, 2017.
, “Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests”, Am J Trop Med Hyg, vol. 92, no. 4, pp. 818-24, 2015.
, “Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects”, PLoS ONE, vol. 11, no. 3, p. e0151898, 2016.
, “The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects”, Sci Rep, vol. 7, no. 1, p. 9822, 2017.
, “Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border [version 2; referees: 2 approved]”, Wellcome Open Res, vol. 2, no. 72, 2017.
, “Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion”, Malar J, vol. 18, no. 1, p. 20, 2019.
, “Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border”, PLoS ONE, vol. 9, no. 12, p. e116063, 2014.
, “Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood”, PLOS ONEPLoS One, vol. 13, p. e0196716, 2018.
, “High hepatitis B seroprevalence and risk factors for infection in pregnant women on the Thailand-Myanmar Border”, Journal of Infections in Developing Countries, vol. 10, no. 04, 2016.
, “In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border”, Malar J, vol. 6, p. 81, 2007.
, “In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial”, Molecules, vol. 22, no. 12, p. 2102, 2017.
, “The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia”, Int J Infect Dis, 2020.
, “Plasmodium vivax malaria: challenges in diagnosis, treatment and elimination”, Pediatr Infect Dis J, vol. 34, no. 5, pp. 529-31, 2015.
, “Reproductive health and quality of life of young Burmese refugees in Thailand”, Confl Health, vol. 4, p. 5, 2010.
, “Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention”, Sci Transl Med, vol. 6, no. 260, p. 260ra147, 2014.
, “Electrocardiographic monitoring in severe falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3. pp. 266-9, 1996.
, “Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review”, Antivir Ther, 2019.
, “Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy”, BMJ Open, vol. 10, no. 9, p. e038123, 2020.
, “Maternal Hepatitis B Infection Burden, Comorbidity and Pregnancy Outcome in a Low-Income Population on the Myanmar-Thailand Border: A Retrospective Cohort Study”, J Pregnancy, vol. 2019, p. 8435019, 2019.
, “Retrospective Review of Documentation Practices of Hepatitis B Immunoglobulin, Birth Dose, and Vaccination at the Hospital of Birth, in Thai Nationals and Migrants in Northern Thailand”, Open Forum Infect Dis, vol. 6, no. 12. p. ofz518, 2019.
, “The antimalarial ferroquine: from bench to clinic”, Parasite, vol. 18, no. 3, pp. 207-14, 2011.
, “Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3”, PLoS ONE, vol. 8, no. 2, p. e56061, 2013.
, “Genetic typing of the 56-kDa type-specific antigen gene of contemporary Orientia tsutsugamushi isolates causing human scrub typhus at two sites in north-eastern and western Thailand”, FEMS Immunol Med Microbiol, vol. 52, no. 3. pp. 335-42, 2008.
, “Underrecognized arthropod-borne and zoonotic pathogens in northern and northwestern Thailand: serological evidence and opportunities for awareness”, Vector Borne Zoonotic Dis, vol. 15, no. 5, pp. 285-90, 2015.
, “No Association of Phenotypic ABO Blood Group and Malaria during Pregnancy”, Am J Trop Med Hyg, vol. 87, no. 3, pp. 447-9, 2012.
, “Castor oil for induction of labour: not harmful, not helpful”, Aust N Z J Obstet Gynaecol, vol. 49, no. 5, pp. 499-503, 2009.
, “Malaria in the post-partum period; a prospective cohort study”, PLoS ONE, vol. 8, no. 3, p. e57890, 2013.
, “Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border”, PLoS Negl Trop Dis, vol. 4, no. 11, p. e887, 2010.
, “The epidemiology of postpartum malaria: a systematic review”, Malar J, vol. 11, p. 114, 2012.
, “Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar”, Malaria Journal, vol. 16, no. 1, p. 480, 2017.
, “Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture”, Int J Parasitol, vol. 42, no. 2, pp. 155-60, 2012.
, “Overcoming Chloroquine Resistance in Malaria: Design, Synthesis and Structure-Activity Relationships of Novel Hybrid Compounds”, Antimicrob Agents Chemother, 2016.
, “Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol”, Infect Immun, vol. 79, no. 9, pp. 3642-52, 2011.
, “Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border”, Emerg Infect Dis, vol. 22, no. 8, pp. 1503-5, 2016.
, “The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites”, Proc Natl Acad Sci U S A, vol. 105, no. 42, pp. 16290-5, 2008.
, “The sick placenta-the role of malaria”, PLACENTA, vol. 25, no. 5, pp. 359-78, 2014.
, “Erratum: Field Evaluation of a Novel Colorimetric Method-Double-Site Enzyme-Linked Lactate Dehydrogenase Immunodetection Assay-To Determine Drug Susceptibilities of Plasmodium falciparum Clinical Isolates from Northwestern Thailand”, Antimicrob Agents Chemother, vol. 48, no. 8, p. 3214, 2004.
, “Plasmodium falciparum antimalarial drug susceptibility on the north- western border of Thailand during five years of extensive use of artesunate-mefloquine”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 537-44., 2000.
, “Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 1, pp. 14-21, 1999.
, “Field Evaluation of a Novel Colorimetric Method-Double-Site Enzyme-Linked Lactate Dehydrogenase Immunodetection Assay-To Determine Drug Susceptibilities of Plasmodium falciparum Clinical Isolates from Northwestern Thailand”, Antimicrob Agents Chemother, vol. 48, no. 4, pp. 1426-1429, 2004.
, “The natural course of a localized BCG vaccine abscess”, Vaccine, vol. 37, no. 20, p. 2757, 2019.
, “Cohort profile: molecular signature in pregnancy (MSP): longitudinal high-frequency sampling to characterise cross-omic trajectories in pregnancy in a resource-constrained setting”, BMJ Open, vol. 10, no. 10, p. e041631, 2020.
, “Blood gene transcript signature profiling in pregnancies resulting in preterm birth: A systematic review”, Eur J Obstet Gynecol Reprod Biol X, vol. 8, p. 100118, 2020.
, “A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol”, BMJ Open, vol. 9, no. 1, p. e023417, 2019.
, “A blind passenger: a rare case of documented seroconversion in an Angiostrongylus cantonensis induced eosinophilic meningitis in a traveler visiting friends and relatives”, Trop Dis Travel Med Vaccines, vol. 5, p. 6, 2019.
, “Subcutaneous abscess formation in septic melioidosis, devoid of associated risk factors”, IDCases, vol. 4, pp. 23-23, 2016.
, “Vivax malaria in pregnancy and lactation: a long way to health equity”, Malar J, vol. 19, no. 1, p. 40, 2020.
, “Comparative 3D genome organization in apicomplexan parasites”, Proc Natl Acad Sci U S A, vol. 116, no. 8, pp. 3183-3192, 2019.
, “Changes in genome organization of parasite-specific gene families during the Plasmodium transmission stages”, Nature Communications, vol. 9, p. 1910, 2018.
, “The reality of using primaquine”, Malar J, vol. 9, no. 1, p. 376, 2010.
, “Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assay”, PLoS ONE, vol. 6, no. 6, p. e20251, 2011.
, “Barriers to immunization among children of migrant workers from Myanmar living in Tak province, Thailand”, Bull World Health Organ, vol. 89, no. 7, pp. 528-31, 2011.
, “Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment”, PLoS ONE, vol. 4, no. 2, p. e4551, 2009.
, “Growth velocity of term infants born in Maela camp for displaced population along the Thai-Myanmar border”, in 19th Internatiinal Congress of Nutrition, Bangkok, Thailand, 2009, vol. 55, p. 299.
, “MUAC and BMI: usefulness in pregnancy among refugee and migrant population along the Thai-Myanmar border”, in 19th International Congress of Nutrition, Bangkok, Thailand, 2009, vol. 55, p. 215.
, “Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative”, PLoS Med, vol. 3, no. 6, p. e183, 2006.
, “Longer exposure to a new refugee food ration is associated with reduced prevalence of small for gestational age: results from 2 cross-sectional surveys on the Thailand-Myanmar border”, Am J Clin Nutr, vol. 105, no. 6, pp. 1382-1390, 2017.
, “Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand”, Malar J, vol. 7, no. 1, p. 233, 2008.
, “Improved pregnancy outcome in refugees and migrants despite low literacy on the Thai-Burmese border: results of three cross-sectional surveys”, BMC Pregnancy and Childbirth, vol. 11, no. 1, p. 45, 2011.
, “Evaluation and Acceptability of a Simplified Test of Visual Function at Birth in a Limited-Resource Setting”, PLoS One, vol. 11, no. 6, p. e0157087, 2016.
, “Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study”, PLoS Med, vol. 10, no. 3, p. e1001398, 2013.
, “TB outcomes and mortality risk factors in adult migrants at the Thailand-Myanmar border”, Int J Tuberc Lung Dis, vol. 24, no. 10, pp. 1009-1015, 2020.
, “Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance”, Genome Biol, vol. 18, no. 1, p. 78, 2017.
, “Can we teach an old drug new tricks?”, Trends Parasitol, 2012.
, “Validation of a chloroquine-induced cell death mechanism for clinical use against malaria”, Cell Death Dis, vol. 5, p. e1305, 2014.
, “A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria”, Sci Rep, vol. 3, p. 1734, 2013.
, “A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection”, Malar J, vol. 13, no. 1, p. 4, 2014.
, “Inhibitory activities of sulfated proteoglycans on chondroitin sulfate A-mediated cytoadherence of Plasmodium falciparum isolates from Thailand”, Am J Trop Med Hyg, vol. 70, no. 2, pp. 149-57, 2004.
, “Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data”, PLOS Medicine, vol. 17, no. 3, p. e1003040, 2020.
, “Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species”, J Infect Dis, vol. 210, no. 10, pp. 1616-26, 2014.
, “Trichuris trichiura infection is associated with the multiplicity of Plasmodium falciparum infections, in Thailand”, Ann Trop Med Parasitol, vol. 97, no. 2, pp. 199-202, 2003.
, “Storage duration and polymerase chain reaction detection of Plasmodium falciparum from blood spots on filter paper”, Am J Trop Med Hyg, vol. 69, no. 1, pp. 42-4, 2003.
, “Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting”, Sci Rep, vol. 6, p. 20859, 2016.
, “Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar”, J Infect Dis, vol. 219, no. 9, pp. 1499-1509, 2019.
, “Insecticide resistance in malaria vectors along the Thailand-Myanmar border”, Parasit Vectors, vol. 10, no. 1, p. 165, 2017.
, “The contribution of asymptomatic Plasmodium infections to the transmission of malaria in Kayin state, Myanmar”, J Infect DisJ Infect Dis, 2018.
, “Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages”, Wellcome Open Res, vol. 3, p. 109, 2018.
, “Comparison of the Performances of Five Primer Sets for the Detection and Quantification of Plasmodium in Anopheline Vectors by Real-Time PCR”, PLoS One, vol. 11, no. 7, p. e0159160, 2016.
, “Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages [version 1; referees: 2 approved with reservations]”, Wellcome Open ResearchWellcome Open Research, vol. 3, 2018.
, “Longevity of the insecticidal effect of three pyrethroid formulations applied to outdoor vegetation on a laboratory-adapted colony of the Southeast Asian malaria vector Anopheles dirus”, PLoS One, vol. 15, no. 4, p. e0231251, 2020.
, “Impact of outdoor residual spraying on the biting rate of malaria vectors: A pilot study in four villages in Kayin state, Myanmar”, PLOS ONE, vol. 15, no. 10, p. e0240598, 2020.
, “Perceived Benefits, Harms, and Views About How to Share Data Responsibly: A Qualitative Study of Experiences With and Attitudes Toward Data Sharing Among Research Staff and Community Representatives in Thailand”, J Empir Res Hum Res Ethics, vol. 10, no. 3, pp. 278-89, 2015.
, “Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt”, International Health, vol. 2, no. 2, pp. 123-129, 2010.
, “Challenges arising when seeking broad consent for health research data sharing: a qualitative study of perspectives in Thailand”, BMC medical ethics, vol. 19, no. 1, p. 86, 2018.
, “Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda”, Trop Med Int Health, vol. 9, no. 4, pp. 445-50, 2004.
, “Pooled sequencing and rare variant association tests for identifying the determinants of emerging drug resistance in malaria parasites”, Mol Biol Evol, vol. 32, no. 4, pp. 1080-90, 2015.
, “A Major Genome Region Underlying Artemisinin Resistance in Malaria”, Science, vol. 336, no. 6077, pp. 79-82, 2012.
, “Population Structure Shapes Copy Number Variation in Malaria Parasites”, Molecular Biology and Evolution, vol. 33, no. 3, pp. 603-20, 2016.
, “Comprehensive Identification of Single Nucleotide Polymorphisms Associated with Beta-lactam Resistance within Pneumococcal Mosaic Genes”, PLoS Genet, vol. 10, no. 8, p. e1004547, 2014.
, “Dense genomic sampling identifies highways of pneumococcal recombination”, Nat Genet, vol. 46, no. 3, pp. 305-9, 2014.
, “Unambiguous determination of Plasmodium vivax reticulocyte invasion by flow cytometry”, Int J Parasitol, vol. 46, no. 1, pp. 31-9, 2016.
, “Central role of the spleen in malaria parasite clearance”, Journal of Infectious Diseases, vol. 185, no. 10, pp. 1538-41., 2002.
, “Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children”, Nat Commun, vol. 10, no. 1, p. 480, 2019.
, “Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens”, PLoS Med, vol. 14, no. 2, p. e1002224, 2017.
, “Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure”, Am J Trop Med Hyg, vol. 102, no. 1, pp. 147-150, 2020.
, “Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation”, Br J Haematol, vol. 180, no. 1, pp. 118-133, 2018.
, “Two fatal cases of melioidosis on the Thai-Myanmar border”, F1000Res, vol. 3, p. 4, 2014.
, “Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter”, Wellcome Open Res, vol. 5, p. 21, 2020.
, “Tafenoquine and G6PD: a primer for clinicians”, J Travel Med, vol. 26, no. 4, 2019.
, “Primaquine-induced haemolysis in females heterozygous for G6PD deficiency”, Malar J, vol. 17, no. 1, p. 101, 2018.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clinical Infectious Diseases, 2018.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 68, no. 8, pp. 1311-1319, 2019.
, “Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure”, Am J Trop Med Hyg, vol. 102, no. 1, pp. 147-150, 2019.
, “Management of relapsing Plasmodium vivax malaria”, Expert Rev Anti Infect Ther, 2016.
, “Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 67, no. 10, pp. 1543-1549, 2018.
, “The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis”, Wellcome Open Res, vol. 4, p. 25, 2019.
, “Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages”, Nat Commun, vol. 10, no. 1, p. 3635, 2019.
, “Hepatic spheroids used as an in vitro model to study malaria relapse”, Biomaterials, vol. 216, p. 119221, 2019.
, “Is areca innocent? The effect of areca (betel) nut chewing in a population of pregnant women on the Thai-Myanmar border”, Int Health, vol. 4-172, no. 3, pp. 204-209, 2012.
, “Comparability of tympanic and oral mercury thermometers at high ambient temperatures”, BMC Res Notes, vol. 5, no. 1, p. 356, 2012.
, “The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis”, Lancet Infect Dis, vol. 18, no. 9, pp. 1025-1034, 2018.
, “The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis”, BMC Med, vol. 17, no. 1, p. 151, 2019.
, “The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis”, PLoS Med, vol. 16, no. 10, p. e1002928, 2019.
, “Challenges and prospects for dengue and malaria control in Thailand, Southeast Asia”, Trends Parasitol, 2013.
, “In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidate”, Malar J, vol. 17, no. 1, p. 20, 2018.
, “Malaria in children”, Lancet, vol. 375, no. 9724, pp. 1468-81, 2010.
, “Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants”, J Infect Dis, vol. 207, no. 11, pp. 1646-54, 2013.
, “Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?”, Expert Opin Drug Saf, vol. 15, no. 3, pp. 367-82, 2016.
, “Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape”, Genome Biol Evol, vol. 6, no. 7, pp. 1589-602, 2014.
, “Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia”, AAPS J, 2017.
, “Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria”, Clin Infect Dis, vol. 56, no. 5, pp. e48-58, 2013.
, “Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections”, Am J Trop Med Hyg, 2017.
, “Leveraging crowdsourcing to accelerate global health solutions”, Nat Biotechnol, vol. 37, no. 8, pp. 848-850, 2019.
, “Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda”, Malaria Journal, vol. 15, no. 1, pp. 1-9, 2016.
, “Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment”, Malar J, vol. 12, no. 1, p. 139, 2013.
, “Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge”, Sci Rep, vol. 8, no. 1, p. 1118, 2018.
, “Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax”, Frontiers in Immunology, vol. 6, 2015.
, “First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies”, PLoS Med, vol. 14, no. 5, p. e1002290, 2017.
, “The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites”, Sci Rep, vol. 7, no. 1, p. 2325, 2017.
, “Epidemiology and burden of malaria in pregnancy”, Lancet Infect Dis, vol. 7, no. 2, pp. 93-104, 2007.
, “Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis”, PLoS Negl Trop Dis, vol. 11, no. 5, p. e0005602, 2017.
, “Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis”, BMC Infect Dis, vol. 17, no. 1, p. 552, 2017.
, “Towards harmonization of microscopy methods for malaria clinical research studies”, Malaria Journal, vol. 19, no. 1, p. 324, 2020.
, “Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial”, Lancet Infect Dis, 2016.
, “Bed nets for the prevention of malaria and anaemia in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 6. pp. 620-6, 1993.
, “The relationship between age and the manifestations of and mortality associated with severe malaria”, Clin Infect Dis, vol. 47, no. 2, pp. 151-7, 2008.
, “Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials”, Trop Med Int Health, vol. 9, no. 12, pp. 1241-6, 2004.
, “Artemisinin Resistance in Plasmodium falciparum Malaria”, New England Journal of Medicine, vol. 361, no. 5, pp. 455-467, 2009.
, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial”, Lancet, vol. 366, no. 9487, pp. 717-25, 2005.
, “Artemisinin Resistance in Plasmodium falciparum Malaria (response)”, New England Journal of Medicine, vol. 361, no. 18, pp. 1807-1808, 2009.
, “Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics”, Clin Infect Dis, vol. 52, no. 5, pp. 612-20, 2011.
, “Artemisinin combination therapy for vivax malaria”, Lancet Infect Dis, vol. 10, no. 6, pp. 405-16, 2010.
, “Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax”, Journal of Infectious Diseases, vol. 208, no. 5, pp. 801-812, 2013.
, “A research agenda for malaria eradication: drugs”, PLoS Med, vol. 8, no. 1, p. e1000402, 2011.
, “International gestational age-specific centiles for umbilical artery Doppler indices: a longitudinal prospective cohort study of the INTERGROWTH-21(st) Project”, Am J Obstet Gynecol, vol. 222, no. 6, pp. 602 e1-602 e15, 2020.
, “Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia”, Malar J, vol. 18, no. 1, p. 114, 2019.
, “Malaria epidemic in Burundi”, Lancet, vol. 357, no. 9261, pp. 1046-7., 2001.
, “Risky alcohol use among reproductive-age men, not women, in Mae La refugee camp, Thailand, 2009”, Conflict and Health, vol. 6, no. 1, p. 7, 2012.
, “Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 44, no. 3, pp. 697-704, 2000.
, “Living with severe perinatal depression: a qualitative study of the experiences of labour migrant and refugee women on the Thai-Myanmar border”, BMC psychiatry, vol. 18, no. 1, p. 229, 2018.
, “Migrant perinatal depression study: a prospective cohort study of perinatal depression on the Thai-Myanmar border”, BMJ Open, vol. 8, no. 1, p. e017129, 2018.
, “Pregnant migrant and refugee women's perceptions of mental illness on the Thai-Myanmar border: a qualitative study”, BMC Pregnancy Childbirth, vol. 15, p. 93, 2015.
, “Maternal suicide risk among refugees and migrants”, Int J Gynaecol Obstet, 2016.
, “Prevalence and determinants of perinatal depression among labour migrant and refugee women on the Thai-Myanmar border: a cohort study”, BMC Psychiatry, vol. 20, no. 1, p. 168, 2020.
, “Paired suicide in a young refugee couple on the Thai-Myanmar border”, BMJ Case Rep, vol. 2016, 2016.
, “Validation of the Refugee Health Screener-15 for the assessment of perinatal depression among Karen and Burmese women on the Thai-Myanmar border”, PloS one, vol. 13, no. 5, p. e0197403, 2018.
, “Characterization of Solid Counterfeit Drug Samples by Desorption Electrospray Ionization and Direct-analysis-in-real-time Coupled to Time-of-flight Mass Spectrometry”, ChemMedChem, vol. 1, no. 7, pp. 702-705, 2006.
, “Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives”, Malar J, vol. 12, no. 1, p. 411, 2013.
, “The invisible burden of malaria-attributable stillbirths”, The Lancet, vol. 395, no. 10220, p. 268, 2020.
, “New insights into acquisition, boosting and longevity of immunity to malaria in pregnant women”, J Infect Dis, 2012.
, “Antibody boosting and longevity following tetanus immunization during pregnancy”, Clin Infect Dis, vol. 56, no. 5, pp. 749-50, 2013.
, “Comparative Heterochromatin Profiling Reveals Conserved and Unique Epigenome Signatures Linked to Adaptation and Development of Malaria Parasites”, Cell Host Microbe, vol. 23, no. 3, pp. 407-420 e8, 2018.
, “Maternal antibodies block malaria”, NATURE, vol. 395, no. 6705. pp. 851-2, 1998.
, “Achieving accurate estimates of fetal gestational age and personalised predictions of fetal growth based on data from an international prospective cohort study: a population-based machine learning study”, The Lancet Digital Health, vol. 2, no. 7, pp. e368-e375, 2020.
, “Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from Thailand”, Antimicrob Agents Chemother, 2015.
, “Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline”, Malaria Journal, vol. 14, no. 1, p. 348, 2015.
, “Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures”, Clin Infect Dis, 2018.
, “Evaluation of a treatment protocol for anaemia in pregnancy nested in routine antenatal care in a limited-resource setting”, Glob Health Action, vol. 12, no. 1, p. 1621589, 2019.
, “Gestational diabetes mellitus prevalence in Maela refugee camp on the Thai–Myanmar Border: a clinical report”, Global Health Action, 2014.
, “"I can't read and don't understand": Health literacy and health messaging about folic acid for neural tube defect prevention in a migrant population on the Myanmar-Thailand border”, PLoS One, vol. 14, no. 6, p. e0218138, 2019.
, “Genomic Investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen”, Clin Infect Dis, vol. 60, no. 3, pp. 381-8, 2015.
, “Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite”, Frontiers in Immunology, vol. 8, no. 1275, 2017.
, “Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy”, PLoS One, vol. 11, no. 7, p. e0159347, 2016.
, “Fatty acid composition of milk of refugee Karen and urban Korean mothers. Is the level of DHA in breast milk of Western women compromised by high intake of saturated fat and linoleic acid?”, Nutr Health, vol. 18, no. 4, pp. 319-32, 2007.
, “Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia”, International Journal of Health Geographics, vol. 15, no. 1, p. 37, 2016.
, “Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia”, Int J Health Geogr, vol. 15, no. 1, p. 37, 2016.
, “Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis”, Malaria Journal, vol. 14, no. 1, p. 359, 2015.
, “Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis”, BMC Med, vol. 17, no. 1, p. 1, 2019.
, “Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data”, BMC Medicine, vol. 13, no. 1, p. 227, 2015.
, “Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data”, BMC Med, vol. 14, no. 1, p. 79, 2016.
, “Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax”, Science, vol. 359, no. 6371, pp. 48-55, 2018.
, “Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development”, Lancet Infectious diseases, vol. 2, no. 9, p. 564., 2002.
, “No Evidence of Cardiotoxicity of Atovaquone-Proguanil Alone or in Combination with Artesunate”, Am J Trop Med Hyg, vol. 73, no. 2, pp. 267-268, 2005.
, “Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border”, Infect Genet Evol, vol. 45, pp. 341-346, 2016.
, “The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos”, Ann Trop Med Parasitol, vol. 96, no. 6, pp. 553-7, 2002.
, “Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar”, Trop Med Int Health, vol. 13, no. 1, pp. 91-8, 2008.
, “A new approach for neurological evaluation of infants in resource-poor settings”, Annals of Tropical Paediatrics, vol. 22, no. 4, pp. 355-68., 2002.
, “Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity”, PLoS Negl Trop Dis, vol. 14, no. 7, p. e0008202, 2020.
, “Plasmodium vivax Merozoite Surface Protein 1 Paralog as a Mediator of Parasite Adherence to Reticulocytes”, Infect Immun, vol. 86, no. 9, 2018.
, “Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis”, PLoS ONE, vol. 9, no. 1, p. e87020, 2014.
, “A Simple Score to Predict the Outcome of Severe Malaria in Adults”, Clin Infect Dis, vol. 50, no. 5, pp. 679-685, 2010.
, “Intermittent Preventive Treatment in Pregnancy With Sulfadoxine-Pyrimethamine: The Times They Are A-Changin’”, Clinical Infectious Diseases, 2012.
, “Duplex real-time PCR assay for detection of Streptococcus pneumoniae in clinical samples and determination of penicillin susceptibility”, J Clin Microbiol, vol. 46, no. 8, pp. 2751-8, 2008.
, “‘Because the baby asks for it’: a mixed-methods study on local perceptions toward nutrition during pregnancy among marginalised migrant women along the Myanmar–Thailand border”, Global health action, vol. 11, no. 1, p. 1473104, 2018.
, “The Healthy Baby Flipbook: piloting home-based counseling for refugee mothers to improve infant feeding and water, sanitation, and hygiene (WASH) practices”, Glob Health Action, vol. 12, no. 1, p. 1560115, 2019.
, “Nutrition in transition: historical cohort analysis summarising trends in under- and over-nutrition among pregnant women in a marginalised population along the Thailand-Myanmar border from 1986 to 2016”, Br J Nutr, vol. 121, no. 12, pp. 1413-1423, 2019.
, “Feeding practices and risk factors for chronic infant undernutrition among refugees and migrants along the Thailand-Myanmar border: a mixed-methods study”, BMC Public Health, vol. 19, no. 1, p. 1586, 2019.
, “Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin-piperaquine in patients with acute uncomplicated falciparum malaria in Thailand”, in 5th European Congress on Tropical Medicine and International Health, Amsterdam, the Netherlands, 2007, vol. 12, p. 222.
, “Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border”, Clin Vaccine Immunol, vol. 22, no. 3, pp. 319-26, 2015.
, “Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria”, Antimicrob Agents Chemother, vol. 61, no. 2, 2017.
, “A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan”, Malar J, vol. 11, no. 1, p. 398, 2012.
, “Development and Application of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for the Detection of p,p'-DDE in Human Milk and Comparison of the Results against GC-ECD”, J Agric Food Chem, vol. 60, no. 1, pp. 16-22, 2011.
, “Quality of intrapartum care by skilled birth attendants in a refugee clinic on the Thai-Myanmar border: a survey using WHO Safe Motherhood Needs Assessment”, BMC Pregnancy Childbirth, vol. 15, p. 17, 2015.
, “Keras R-CNN: library for cell detection in biological images using deep neural networks”, BMC Bioinformatics, vol. 21, no. 1, p. 300, 2020.
, “A case control auditory evaluation of patients treated with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 74, no. 2, pp. 211-214, 2006.
, “A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand”, Malar J, vol. 4, no. 1, p. 46, 2005.
, “Long-term storage limits PCR-based analyses of malaria parasites in archival dried blood spots”, Malar J, vol. 11, no. 1, p. 339, 2012.
, “Selective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structure”, Sci Rep, vol. 10, no. 1, p. 10832, 2020.
, “Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study”, Lancet Infect Dis, 2020.
, “Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum”, Antimicrob Agents Chemother, vol. 54, no. 7, pp. 2886-92, 2010.
, “Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax”, J Infect Dis, vol. 203, no. 2, pp. 207-10, 2011.
, “Numerical Distributions of Parasite Densities During Asymptomatic Malaria”, J Infect Dis, vol. 213, no. 8, pp. 1322-9, 2016.
, “The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam”, Malar J, vol. 14, p. 381, 2015.
, “Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites”, J Infect Dis, vol. 195, no. 7, pp. 927-33, 2007.
, “Gene amplification of Plasmodium vivax multidrug resistance 1 gene in Thailand, Laos, and Myanmar”, Antimicrob Agents Chemother, 2008.
, “The First Plasmodium vivax Relapses of Life Are Usually Genetically Homologous”, Journal of Infectious Diseases, 2011.
, “Validation of the Edinburgh Postnatal Depression Scale (EPDS) on the Thai-Myanmar border”, Trop Doct, p. 49475517717635, 2017.
, “Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria”, J Infect Dis, vol. 219, no. 9, pp. 1483-1489, 2019.
, “Early neonatal mortality and neurological outcomes of neonatal resuscitation in a resource-limited setting on the Thailand-Myanmar border: A descriptive study”, PloS one, vol. 13, no. 1, p. e0190419, 2018.
, “Simultaneous Quantification of Plasmodium Antigens and Host Factor C-Reactive Protein in Asymptomatic Individuals with Confirmed Malaria by Use of a Novel Multiplex Immunoassay”, J Clin Microbiol, vol. 57, no. 1, 2019.
, “A new highly sensitive enzyme-linked immunosorbent assay for the detection of Plasmodium falciparum histidine-rich protein 2 in whole blood”, Malar J, vol. 17, no. 1, p. 403, 2018.
, “Simultaneous Quantification of Plasmodium Antigens and Host Factor C-Reactive Protein in Asymptomatic Individuals with Confirmed Malaria by Use of a Novel Multiplex Immunoassay”, J Clin Microbiol, vol. 57, no. 1, 2018.
, “Multiplex Human Malaria Array: Quantifying Antigens for Malaria Rapid Diagnostics”, Am J Trop Med Hyg, vol. 102, no. 6, pp. 1366-1369, 2020.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “Treatment of Suspected Hyper-Reactive Malarial Splenomegaly (HMS) in Pregnancy with Mefloquine”, The American Journal of Tropical Medicine and Hygiene, 2014.
, “Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects”, Antimicrob Agents Chemother, vol. 59, no. 1, pp. 505-13, 2015.
, “Primaquine radical cure of Plasmodium vivax: a critical review of the literature”, Malar J, vol. 11, no. 1, p. 280, 2012.
, “Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms”, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, vol. 24, pp. 111-115, 2014.
, “The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum”, Antimicrob Agents Chemother, vol. 55, no. 3, pp. 1300-4, 2011.
, “Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar”, Wellcome Open Res, vol. 2, p. 59, 2017.
, “The acceptability of mass administrations of anti-malarial drug as part of targeted malaria elimination in villages along the Thai-Myanmar border”, Malar J, vol. 15, no. 1, p. 494, 2016.
, “Immunization Coverage in Migrant School Children Along the Thailand-Myanmar Border”, J Immigr Minor Health, 2015.
, “Challenges in tackling tuberculosis on the Thai-Myanmar border: findings from a qualitative study with health professionals”, BMC Health Serv Res, vol. 15, no. 1, p. 464, 2015.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, 2017.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, vol. 100, no. 3, pp. 294-303, 2018.
, “Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial”, PLOS CLIN TRIALS, vol. 2, no. 5, p. e20, 2007.
, “Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21 (st) Newborn Case-Control Study protocol”, Gates Open Res, vol. 2, p. 49, 2018.
, “Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21 (st) Newborn Case-Control Study protocol”, Gates Open Res, vol. 2, p. 49, 2018.
, “Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol [version 2; referees: 1 approved]”, Gates Open Research, vol. 2, no. 49, p. 49, 2019.
, “Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria”, Journal of Pharmacy and Pharmacology, vol. 64, no. 11, pp. 1603-1613, 2012.
, “Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis”, PLoS medicine, vol. 15, no. 6, p. e1002579, 2018.
, “Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda”, J Antimicrob Chemother, vol. 69, no. 11, pp. 3033-40, 2014.
, “Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation”, Br J Clin Pharmacol, vol. 80, no. 4, pp. 642-53, 2015.
, “Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda”, CPT Pharmacometrics Syst Pharmacol, vol. 2, p. e83, 2013.
, “Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border”, Antimicrob Agents Chemother, vol. 59, no. 10, pp. 6375-84, 2015.
, “Genetic Diversity in New Members of the Reticulocyte Binding Protein Family in Thai Plasmodium vivax Isolates”, PLoS ONE, vol. 7, no. 3, p. e32105, 2012.
, “Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi”, Blood, vol. 130, no. 11, pp. 1357-1363, 2017.
, “Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates”, Exp Parasitol, vol. 114, no. 1, pp. 34-9, 2006.
, “Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 1. pp. 67-73, 1994.
, “KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment and prevention of disease transmission”, Antimicrob Agents Chemother, 2014.
, “High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria”, Journal of Infectious Diseases, vol. 166, no. 6, pp. 1393-400, 1992.
, “Absorption of intramuscular phenobarbitone in children with severe falciparum malaria”, European Journal of Clinical Pharmacology, vol. 42, no. 1. pp. 107-10, 1992.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 6, pp. 660-4, 1995.
, “Mefloquine prophylaxis”, Lancet, vol. 342, p. 551, 1993.
, “Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography”, American Journal of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 778-84, 1994.
, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, vol. 341, pp. 1044-9, 1993.
, “Are Extensive T Cell Epitope Polymorphisms in the Plasmodium falciparum Circumsporozoite Antigen, a Leading Sporozoite Vaccine Candidate, Selected by Immune Pressure?”, J Immunol, vol. 175, no. 6, pp. 3935-9, 2005.
, “A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand”, Southeast Asian J Trop Med Public Health, vol. 35, no. 2, pp. 281-7, 2004.
, “Vector bionomics and malaria transmission along the Thailand-Myanmar border: a baseline entomological survey”, J Vector Ecol, vol. 42, no. 1, pp. 84-93, 2017.
, “Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern Myanmar”, J Clin Microbiol, vol. 56, no. 8. 2018.
, “Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar”, Wellcome Open Res, vol. 2, p. 81, 2017.
, “The role of early detection and treatment in malaria elimination”, Malar J, vol. 15, p. 363, 2016.
, , “Giemsa-Stained Wet Mount Based Method for Reticulocyte Quantification: A Viable Alternative in Resource Limited or Malaria Endemic Settings”, PLoS ONE, vol. 8, no. 4, p. e60303, 2013.
, “A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-dichlorobenzamil on the digestive vacuole of Plasmodium falciparum”, Antimicrob Agents Chemother, vol. 58, no. 1, pp. 550-8, 2014.
, “Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria”, Eur J Clin Pharmacol, 2008.
, “Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes”, Blood, vol. 123, no. 18, pp. e100-e109, 2014.
, “The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria”, Malar J, vol. 7, no. 1, p. 149, 2008.
, “Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis”, eLife, vol. 9, p. e51546, 2020.
, “Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients”, PLoS One, vol. 12, no. 2. p. e0168780, 2017.
, “Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration”, Elife, vol. 6, 2017.
, “Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage”, Proc Natl Acad Sci U S A, 2017.
, “Plasmodium vivax susceptibility to ferroquine”, Antimicrob Agents Chemother, vol. 54, no. 5, pp. 2228-30, 2010.
, “Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum”, Antimicrob Agents Chemother, vol. 52, no. 7, pp. 2435-41, 2008.
, “Severe allergic reactions to oral artesunate: a report of two cases”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 2, pp. 182-3., 2001.
, “Methods for the field evaluation of quantitative G6PD diagnostics: a review”, Malaria Journal, vol. 16, no. 1, p. 361, 2017.
, “Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis”, PLoS Med, vol. 16, no. 12, p. e1002992, 2019.
, “High density of ‘spiky’ excrescences covering the surface of an erythrocyte infected with Plasmodium malariae”, British Journal of Haematology, vol. 151, no. 1, pp. 1-1, 2010.
, “Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis”, Lancet Glob Health, vol. 7, no. 8, pp. e1031-e1045, 2019.
, “Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle”, PLoS Genet, vol. 15, no. 10, p. e1008453, 2019.
, “Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies”, J Chromatogr B Analyt Technol Biomed Life Sci, vol. 876, no. 1, pp. 54-60, 2008.
, “Thanaka (Limonia acidissima) and deet (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women”, Medical and Veterinary Entomology, vol. 12, no. 3, pp. 295-301, 1998.
, “Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria”, N Engl J Med, vol. 380, no. 3, pp. 229-241, 2019.
, “Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQGREEN, as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay”, PLoS One, vol. 9, no. 10, p. e110800, 2014.
, “Consensus recommendation on the treatment of malaria in Southeast Asia”, Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 2, pp. 355-60, 1998.
, “Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review”, Trop Med Int Health, vol. 16, no. 2, pp. 145-51, 2011.
, “Cost-effectiveness of artesunate for the treatment of severe malaria”, Trop Med Int Health, vol. 14, no. 3, pp. 332-7, 2009.
, “Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia”, BMC Infect Dis, vol. 15, no. 1, p. 511, 2015.
, “Naturally acquired immunity to vivax malaria”, Lancet, vol. 354, p. 162, 1999.
, “The epidemiology of malaria in a Karen population on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 105-11, 1996.
, “Health care in refugee camps”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 129-30, 1998.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Mefloquine for multidrug-resistant malaria”, Lancet, vol. 338. p. 1268, 1991.
, “Two patients with falciparum malaria and poor in vivo responses to artesunate”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 6, pp. 668-9, 1998.
, “Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 213-7, 1994.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission”, Am J Epidemiol, vol. 154, no. 5, pp. 459-65, 2001.
, “Beri-beri: the major cause of infant mortality in Karen refugees”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 2, pp. 251-5, 2003.
, “Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 562-3, 1998.
, “Elimination of Plasmodium falciparum in an area of multi-drug resistance”, Malar J, vol. 14, p. 319, 2015.
, “A randomised, double-blind, placebo controlled trial of monthly versus second monthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria”, Antimicrob Agents Chemother, vol. 56, no. 3, pp. 1571-1577, 2012.
, “The practicality and sustainability of a community advisory board at a large medical research unit on the Thai-Myanmar border”, Health, vol. 05, no. 02, pp. 229-236, 2013.
, “Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report”, Malar J, vol. 7, p. 57, 2008.
, “A randomised, double-blind placebo controlled trial of two different dosing regimens of dihydroartemisinin-piperaquine for intermittent preventive treatment of adults at high risk of malaria in Thailand”, in 59th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2010, vol. 83, p. 372.
, “Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border”, BMC Medical Ethics, vol. 15, no. 1, p. 12, 2014.
, “Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse”, Malar J, vol. 12, no. 1, p. 173, 2013.
, “An adaptable soft-mold embossing process for fabricating optically-accessible, microfeature-based culture systems and application toward liver stage antimalarial compound testing”, Lab on a Chip, 2020.
, “Genomic epidemiology of artemisinin resistant malaria”, Elife, vol. 5, 2016.
, “Significant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytes”, PLoS ONE, vol. 8, no. 10, p. e76062, 2013.
, “Plasmodium vivax: restricted tropism and rapid remodelling of CD71 positive reticulocytes”, Blood, 2014.
, “A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development”, Sci. Rep., vol. 1, 2011.
, “Histone methyltransferase inhibitors: orally bioavailable, fast acting molecules with activity against different human malaria species”, Antimicrob Agents Chemother, vol. 59, no. 2, p. 950:959, 2014.
, “Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing”, NATURE, vol. 487, no. 7407, pp. 375-9, 2012.
, “Plasmodium P36 determines host cell receptor usage during sporozoite invasion”, Elife, vol. 6, 2017.
, “G6PD deficiency in malaria endemic areas of Nepal”, Malar J, vol. 19, no. 1, p. 287, 2020.
, “Plasmodium vivax rhomboid-like protease 1 gene diversity in Thailand”, Exp Parasitol, vol. 181, pp. 1-6, 2017.
, “Hypothesis of drug response dynamics to explain recrudescence in artesunate resistant plasmodium falciparum malaria”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 149.
, “Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic”, Clin Infect Dis, vol. 39, no. 8, pp. 1139-47, 2004.
, “In Vitro Antimalarial Drug Susceptibility and Pfcrt Mutation among Fresh Plasmodium Falciparum Isolates from the Lao Pdr (Laos)”, Am J Trop Med Hyg, vol. 76, no. 2, pp. 245-250, 2007.
, “A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos”, Trans R Soc Trop Med Hyg, vol. 97, no. 3, pp. 343-4, 2003.
, “Chloroquine versus Sulfadoxine-Pyrimethamine for Treatment of Plasmodium falciparum Malaria in Savannakhet Province, Lao People's Democratic Republic: An Assessment of National Antimalarial Drug Recommendations”, Clin Infect Dis, vol. 37, no. 8, pp. 1021-8, 2003.
, “Postpartum thiamine deficiency in a Karen displaced population”, American Journal of Clinical Nutrition, vol. 74, no. 6, pp. 808-813, 2001.
, “Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?”, The Lancet, vol. 395, no. 10226, p. 779, 2020.
, “Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report”, Trans R Soc Trop Med Hyg, vol. 97, no. 5, pp. 592-4, 2003.
, “First report of an Orientia tsutsugamushi type TA716-related scrub typhus infection in Thailand”, Vector Borne and Zoonotic Diseases, vol. 10, no. 2, pp. 191-3, 2010.
, “Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria”, Eur J Clin Pharmacol, vol. 62, no. 5, pp. 367-71, 2006.
, “A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy”, PLoS Medicine, vol. 5, no. 12, p. e253, 2008.
, “Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 4, pp. 285-9., 2001.
, “How a refugee community deals with adoption”, BMJ, vol. 326, no. 7394, p. 873, 2003.
, “Pregnancy outcome in relation to treatment of murine typhus and scrub typhus infection: a Fever cohort and a case series analysis”, PLoS Negl Trop Dis, vol. 8, no. 11, p. e3327, 2014.
, “Smoking cheroots reduces birthweight”, Lancet, vol. 352, no. 9139, pp. 1521-2., 1998.
, “Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border”, PLoS Negl Trop Dis, vol. 4, no. 11, p. e888, 2010.
, “The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, vol. 62, no. 12, pp. 1021-31, 2006.
, “Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study”, Lancet Infect Dis, vol. 12, no. 5, pp. 388-396, 2012.
, “The overlap between miscarriage and extreme preterm birth in a limited-resource setting on the Thailand-Myanmar border: a population cohort study”, Wellcome Open Res, vol. 1. p. 32, 2018.
, “Neonatal neurological testing in resource-poor settings”, Annals of Tropical Paediatrics, vol. 20, no. 4, pp. 323-36., 2000.
, “Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil”, European Journal of Clinical Pharmacology, vol. 59, no. 7, pp. 553-557, 2003.
, “The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 93 Suppl 1, pp. S19-23., 1999.
, “The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 180-4., 2002.
, “Symptomatic malaria in pregnancy”, J Obstet Gynaecol, vol. 28, no. 4, p. 463, 2008.
, “Proxies and prevention of malaria in pregnancy”, Lancet Infect Dis, 2012.
, “Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 651-6., 2001.
, “Miscarriage, stillbirth and neonatal mortality in the extreme preterm birth window of gestation in a limited-resource setting on the Thailand-Myanmar border: a population cohort study [version 1; referees: awaiting peer review]”, Wellcome Open Res, vol. 1, no. 32, 2016.
, “Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 92, no. 6, pp. 643-53., 1998.
, “Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration”, Evid Based Med, vol. 15, no. 3, pp. 71-2, 2010.
, “Re: Malaria in pregnancy”, BJOG, vol. 113, no. 2, p. 246, 2006.
, “Menorrhagia caused by dengue fever”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 40, no. 3, pp. 354-5., 2000.
, “The Effects of Plasmodium Falciparum and P. Vivax Infections on Placental Histopathology in an Area of Low Malaria Transmission”, Am J Trop Med Hyg, vol. 70, no. 4, pp. 398-407, 2004.
, “The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria”, European Journal of Clinical Pharmacology, vol. 59, no. 7, pp. 545-552, 2003.
, “Falciparum malaria in pregnancy”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 35, no. 4, pp. 468-9., 1995.
, “Meet my uncle”, Lancet, vol. 353, no. 9150, p. 414., 1999.
, “Haemozoin as a marker of placental parasitization”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 6, pp. 644-6., 2002.
, “Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum”, Clinical Infectious Diseases, vol. 33, no. 12, pp. 2009-16., 2001.
, “Diagnostic and Treatment Difficulties of Pyelonephritis in Pregnancy in Resource-Limited Settings”, Am J Trop Med Hyg, vol. 83, no. 6, pp. 1322-1329, 2010.
, “Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects”, British Journal of Clinical Pharmacology, vol. 73, no. 3, pp. 467-477, 2011.
, “Artemisinin derivatives in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 4, pp. 430-3., 1998.
, “Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010”, PLoS ONE, vol. 7, no. 7, p. e40244, 2012.
, “Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome”, Malar J, vol. 13, no. 1, p. 191, 2014.
, “A Randomized Comparison of Artesunate-Atovaquone-Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during Pregnancy”, J Infect Dis, vol. 192, no. 5, pp. 846-853, 2005.
, “A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 2, pp. 137-8., 2001.
, “Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 689-93., 2000.
, “Malaria and the pregnant traveller”, Travel Medicine and Infectious Disease, vol. 2, no. 3-4, pp. 127-142, 2004.
, “Acquired haemophilia A in early pregnancy associated with Plasmodium vivax malaria and hyperthyroidism”, Aust N Z J Obstet Gynaecol, vol. 47, no. 1, pp. 76-7, 2007.
, “Delayed visual maturation in Karen refugee infants”, Annals of Tropical Paediatrics, vol. 23, no. 3, pp. 193-204, 2003.
, “Which drug is effective and safe for acute malaria in pregnancy? Reviewing the evidence”, Drug Development Research, vol. 71, no. 1, pp. 56-68, 2010.
, “Obstetric ultrasound aids prompt referral of gestational trophoblastic disease in marginalized populations on the Thailand-Myanmar border”, Glob Health Action, vol. 10, no. 1, p. 1296727, 2017.
, “P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission”, PLoS One, vol. 12, no. 10, p. e0186577, 2017.
, “Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period”, Sci Rep, vol. 6, p. 32159, 2016.
, “Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum”, Am J Trop Med Hyg, vol. 96, no. 5, pp. 1197-1204, 2017.
, “Targeting Plasmodium PI(4)K to eliminate malaria”, NATURE, 2013.
, “Development, validation and evaluation of a rapid PCR-nucleic acid lateral flow immuno-assay for the detection of Plasmodium and the differentiation between Plasmodium falciparum and Plasmodium vivax”, Malar J, vol. 11, no. 1, p. 279, 2012.
, “Direct blood PCR in combination with Nucleic Acid Lateral Flow Immuno-Assay for the detection of Plasmodium species in malaria endemic settings”, J Clin Microbiol, 2012.
, “Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015)”, Malar J, vol. 18, no. 1, p. 240, 2019.
, “SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand”, Acta Tropica, vol. 67, no. 3, pp. 215-27, 1997.
, “Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia”, Nat Genet, vol. 45, no. 6, pp. 648-55, 2013.
, “Genetic architecture of artemisinin-resistant Plasmodium falciparum”, Nat Genet, vol. 47, no. 3, pp. 226-34, 2015.
, “Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription”, BMC Genomics, vol. 12, no. 1, p. 391, 2011.
, “Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance”, Science, vol. 347, no. 6220, pp. 431-5, 2015.
, “Image-scoring system for umbilical and uterine artery pulsed-wave Doppler ultrasound measurement”, Ultrasound Obstet Gynecol, vol. 53, no. 2, pp. 251-255, 2019.
, “Image scoring system for umbilical and uterine artery pulsed wave Doppler ultrasound measurement”, Ultrasound in Obstetrics & Gynecology, 2018.
, “Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study”, Lancet Infect Dis, 2016.
, “Estimating Gestational Age in Late Presenters to Antenatal Care in a Resource-Limited Setting on the Thai-Myanmar Border”, PLoS One, vol. 10, no. 6, p. e0131025, 2015.
, “Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis”, The Lancet Global Health, 2017.
, “Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis”, BMC Med, vol. 15, no. 1, p. 98, 2017.
, “A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission”, J Infect Dis, vol. 202, no. 10, pp. 1608-16, 2010.
, “Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial”, Malar J, vol. 11, no. 1, p. 150, 2012.
, “Placental malaria in areas of different endemicity: a modified pathological grading scheme”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 39.
, , “A systematic overview of published antimalarial drug trials”, Trans R Soc Trop Med Hyg, vol. 98, no. 2, pp. 73-81, 2004.
, “Efficacy and safety of dihydroartemisinin-piperaquine”, Trans R Soc Trop Med Hyg, vol. 101, no. 9, pp. 858-66, 2007.
, “Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria”, Am J Trop Med Hyg, vol. 77, no. 3, pp. 447-50, 2007.
, “Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study”, BJOG, vol. 114, no. 5, pp. 582-587, 2007.
, “Does the shape of Plasmodium falciparum gametocytes have a function?”, Med Hypotheses, vol. 62, no. 4, pp. 618-9, 2004.
, “Made in Europe: will artemisinin resistance emerge in French Guiana?”, Malar J, vol. 12, p. 152, 2013.
, “Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy”, Trans R Soc Trop Med Hyg, vol. 97, no. 3, pp. 273-6, 2003.
, “Photoallergy to quinine”, Trop Doct, vol. 35, no. 2, pp. 117-8, 2005.
, “Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand”, Ann Trop Med Parasitol, vol. 98, no. 2, pp. 115-20, 2004.
, “Fitness Costs and the Rapid Spread of kelch13-C580Y Substitutions Conferring Artemisinin Resistance”, Antimicrob Agents Chemother, vol. 62, no. 9, 2018.
, “Adaptive copy number evolution in malaria parasites”, PLOS GENET, vol. 4, no. 10, p. e1000243, 2008.
, “Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension”, International Journal of Parasitology, vol. 32, no. 7, pp. 852-8., 2002.
, “Genetic changes during laboratory propagation: copy number At the reticulocyte-binding protein 1 locus of Plasmodium falciparum”, Mol Biochem Parasitol, vol. 172, no. 2, pp. 145-8, 2010.
, “Single-cell genomics for dissection of complex malaria infections”, Genome research, vol. 24, no. 6, pp. 1028-1038, 2014.
, “Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites”, MOL BIOL EVOL, vol. 24, no. 2, pp. 562-73, 2007.
, “A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites”, Molecular Biology and Evolution, vol. 20, no. 9, pp. 1526-36, 2003.
, “Limited polymorphism of the Kelch propeller domain in P. malariae and P. ovale isolates from Thailand”, Antimicrob Agents Chemother, 2016.
, “Selection strength and hitchhiking around two anti-malarial resistance genes”, Proc Biol Sci, vol. 272, no. 1568, pp. 1153-61, 2005.
, “Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice”, Med Microbiol Immunol, vol. 207, no. 5-6, pp. 271-286, 2018.
, “The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data”, PLoS Med, vol. 10, no. 12, p. e1001564, 2013.
, “The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data”, Lancet Infect Dis, vol. 15, no. 6, pp. 692-702, 2015.
, “Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 46, no. 4, pp. 1125-7., 2002.
, “Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria”, Antimicrob Agents Chemother, vol. 49, no. 4, pp. 1622-5, 2005.
, “Correction: Manslaughter by Fake Artesunate in Asia‚ÄîWill Africa Be Next?”, PLoS Med, vol. 3, no. 8, p. e324, 2006.
, “Fake artesunate in southeast Asia”, Lancet, vol. 357, no. 9272, pp. 1948-50., 2001.
, “Manslaughter by fake artesunate in Asia--will Africa be next?”, PLoS Med, vol. 3, no. 6, p. e197, 2006.
, “Population genetic correlates of declining transmission in a human pathogen”, Mol Ecol, vol. 22, no. 2, pp. 273-85, 2013.
, “Close kinship within multiple-genotype malaria parasite infections”, Proceedings of the Royal Society B: Biological Sciences, 2012.
, “Genetic Evaluation of the Performance of Malaria Parasite Clearance Rate Metrics”, J Infect Dis, 2013.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?”, CNS DRUGS, vol. 11, no. 1, pp. 1-8, 1999.
, “Waking the Sleeping Beauty”, The Journal of Infectious Diseases, vol. 202, no. 9, pp. 1300-1301, 2010.
, “Letters to the Editor”, The American Journal of Tropical Medicine and Hygiene, vol. 74, no. 6, p. 940, 2006.
, “Use of artemisinin derivatives for the control of malaria”, Medecine Tropicale, vol. 58, no. 3, pp. 45-9, 1998.
, “Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective”, Malar J, vol. 14, no. 1, p. 248, 2015.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “Prophylactic effect of Malarone against malaria: all good news?”, Lancet, vol. 356, no. 9245, pp. 1864-5, 2000.
, “New antimalarials. A risk-benefit analysis”, DRUG SAFETY, vol. 12, no. 4, pp. 264-73, 1995.
, “Treatment of multidrug-resistant Plasmodium falciparum malaria with 3- day artesunate-mefloquine combination”, Journal of Infectious Diseases, vol. 170, no. 4, pp. 971-7, 1994.
, “Effects of Plasmodium vivax malaria in pregnancy”, Lancet, vol. 354, no. 9178, pp. 546-9, 1999.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
, “We still need artesunate monotherapy”, BMJ, vol. 333, no. 7557, p. 45, 2006.
, “Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 3, pp. 305-306, 1993.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
, “Halofantrine in the Treatment of Malaria”, DRUG SAFETY, vol. 13, no. 4, pp. 271-272, 1995.
, “Artemisinin: large community studies”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88 Suppl 1, pp. S45-6, 1994.
, “Safety and efficacy of artemether-lumefantrine in the treatment of acute, uncomplicated falciparum malaria in adults: a pooled analysis of individual patient data”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 245.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study”, British Journal of Clinical Pharmacology, vol. 30, no. 1. pp. 79-85, 1990.
, “Malaria in pregnancy and the endemicity spectrum: what can we learn?”, Trends in Parasitology, vol. 20, no. 9, pp. 425-432, 2004.
, “Artemisinin-Based Combination Treatment of Falciparum Malaria”, The American Journal of Tropical Medicine and Hygiene, vol. 77, no. 6 Suppl, pp. 181-192, 2007.
, “Modes d'action et caracteristiques pharmacologiques des antipaludiques”, Medecine et Maladies Infectieuses, vol. 29, Supplement 3, pp. S307-S315, 1999.
, “Intrarectal artemisinin derivatives”, Medecine Tropicale, vol. 58, no. 3, pp. 63-4, 1998.
, “[Malaria in pregnancy: a therapeutic dilemma]”, Med Sci (Paris), vol. 25, no. 10, pp. 867-9, 2009.
, “Malaria misconceptions”, Lancet, vol. 365, no. 9460, p. 653, 2005.
, “Malaria: still no vaccine and very few drugs”, Current Opinion in Infectious Diseases, vol. 9, no. 6, pp. 429-434, 1996.
, “The detection and treatment of Plasmodium falciparum malaria: Time for change”, Journal of Postgraduate Medicine, vol. 50, no. 1, pp. 35-9, 2004.
, “Case management of malaria in pregnancy”, Lancet Infect Dis, vol. 7, no. 2, pp. 118-25, 2007.
, “The effects of mefloquine treatment in pregnancy”, Clinical Infectious Diseases, vol. 28, no. 4, pp. 808-15, 1999.
, “Combination therapy for malaria: the way forward?”, Drugs, vol. 62, no. 9, pp. 1315-29, 2002.
, “Beriberi in Cambodia”, Paediatr Int Child Health, p. 2046905515Y0000000015, 2015.
, “Pyronaridine-artesunate for uncomplicated falciparum malaria”, Lancet, vol. 375, no. 9724, pp. 1413-4, 2010.
, “Antimalarial drugs in pregnancy: a review”, Current Drug Safety, vol. 1, no. 1, pp. 1-16, 2006.
, “Community based studies on the treatment of multi-drug resistant falciparum malaria”, in ICOPA IX - 9th International congress of parasitology, Nakasaki, Japan, 1998, pp. 523-528.
, “[Malaria control in Plasmodium falciparum resistant to multi-therapy a field opinion]”, Med Trop (Mars), vol. 65, no. 1, pp. 91-2, 2005.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “New malaria maps”, Lancet, vol. 394, no. 10195, pp. 278-279, 2019.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
, “Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study”, Lancet, vol. 356, no. 9226, pp. 297-302, 2000.
, “Two-phase importance sampling for inference about transmission trees”, Proceedings of the Royal Society B: Biological Sciences, vol. 281, no. 1794, 2014.
, “Climate induces seasonality in pneumococcal transmission”, Sci Rep, vol. 5, p. 11344, 2015.
, “Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives”, J Infect Dis, vol. 220, no. 7, pp. 1178-1187, 2019.
, “Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates”, J Infect Dis, 2014.
, “A randomised controlled trial of 3 versus 5 days artemether-lumefantrine regimen for uncomplicated Plasmodium falciparum treatment in pregnancy in Africa”, Antimicrob Agents Chemother, 2019.
, “A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa”, Antimicrob Agents Chemother, vol. 64, no. 3, 2020.
, “A randomized comparison of the efficacy and tolerability of three artemisinin-based combination treatments for children with acute falciparum malaria in The Democratic Republic of Congo”, Antimicrob Agents Chemother, 2014.
, “Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar”, PLoS ONE, vol. 11, no. 4, p. e0152304, 2016.
, “Video-based feedback as a method for training rural healthcare workers to manage medical emergencies: a pilot study”, BMC Med Educ, vol. 17, no. 1, p. 149, 2017.
, “Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects”, Am J Trop Med Hyg, vol. 92, no. 1, pp. 22-7, 2015.
, “Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient”, Am J Trop Med Hyg, vol. 100, no. 1, pp. 213-221, 2019.
, “Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient”, Am J Trop Med Hyg, vol. 100, no. 1. pp. 213-221, 2018.
, “Singapore's Anopheles sinensis Form A is susceptible to Plasmodium vivax isolates from the western Thailand-Myanmar border”, Malar J, vol. 16, no. 1, p. 465, 2017.
, “Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border”, Malar J, vol. 15, no. 1, p. 571, 2016.
, “Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar [version 2; referees: 2 approved]”, Wellcome Open Res, vol. 2, no. 98, 2017.
, “Herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations and the implications for malaria elimination”, bioRxiv, p. 393843, 2018.
, “Microgeography and molecular epidemiology of malaria at the Thailand-Myanmar border in the malaria pre-elimination phase”, Malar J, vol. 14, p. 198, 2015.
, “Trends and birth outcomes in adolescent refugees and migrants on the Thailand-Myanmar border, 1986-2016: an observational study”, Wellcome Open Research, vol. 3, 2018.
, “Malaria ecology along the Thailand-Myanmar border”, Malar J, vol. 14, no. 1, p. 388, 2015.
, “A multi-level spatial analysis of clinical malaria and subclinical Plasmodium infections in Pailin Province, Cambodia”, Heliyon, vol. 3, no. 11, p. e00447, 2017.
, “Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations”, Elife, vol. 8, 2019.
, “Clinical audit to enhance safe practice of skilled birth attendants for the fetus with nuchal cord: evidence from a refugee and migrant cohort”, BMC Pregnancy Childbirth, vol. 14, no. 1, p. 76, 2014.
, “Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 6, pp. 672-4, 2003.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand”, The American Journal of Tropical Medicine and Hygiene, vol. 58, no. 2, pp. 195-203, 1998.
, “Genomic analysis of local variation and recent evolution in Plasmodium vivax”, Nat Genet, vol. advance online publication, 2016.
, “Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials”, Malar J, vol. 18, no. 1, p. 428, 2019.
, “Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region”, PLoS One, vol. 14, no. 3, p. e0214280, 2019.
, “Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine”, Antimicrob Agents Chemother, 2017.
, “Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis”, PLOS Medicine, vol. 17, no. 5, p. e1003084, 2020.
, “Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria”, International Journal of Clinical Pharmacology and Therapeutics, vol. 37, no. 1, pp. 58-61, 1999.
, “Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials”, PLoS One, vol. 15, no. 2, p. e0228190, 2020.
, “Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors”, Clin Infect Dis, vol. 63, no. 6, pp. 784-91, 2016.
, “Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial”, Clin Infect Dis, vol. 53, no. 10, pp. 977-84, 2011.
, “Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial”, Lancet Infect Dis, 2015.
, “Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border”, Malar J, vol. 17, no. 1, p. 30, 2018.
, “Challenges to replace ACT as first-line drug”, Malar J, vol. 16, no. 1, p. 296, 2017.
, “Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins”, Parasite, vol. 2, no. 3, pp. 263-8, 1995.
, “Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar”, Malaria Journal, vol. 19, no. 1, p. 315, 2020.
, “Efficacy and safety of quinine vs artemether-lumefantrine in uncomplicated malaria during pregnancy, Mbarara, Uganda”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 8.
, “Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial”, The Lancet Infectious Diseases, vol. 10, no. 11, pp. 762-769, 2010.
, “Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria”, Malar J, vol. 16, no. 1, p. 134, 2017.
, “Low seroprevalence of HIV and syphilis in pregnant women in refugee camps on the Thai-Burma border”, Int J STD AIDS, vol. 19, no. 12, pp. 833-7, 2008.
, “Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic”, Clin Infect Dis, vol. 46, no. 9, pp. 1374-81, 2008.
, “Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship”, Malar J, vol. 10, no. 1, p. 374, 2011.
, “Ancillary Care: From Theory to Practice in International Clinical Research”, Public Health Ethics, vol. 6, no. 2, pp. 154-169, 2013.
, “Exploitation and community engagement: can community advisory boards successfully assume a role minimising exploitation in international research?”, Dev World Bioeth, vol. 15, no. 1, pp. 18-26, 2015.
, “Linking international clinical research with stateless populations to justice in global health”, BMC Med Ethics, vol. 15, no. 1, p. 49, 2014.
, “Closing the translation gap for justice requirements in international research”, J Med Ethics, vol. 38, no. 9, pp. 552-558, 2012.
, “VarB: a variation browsing and analysis tool for variants derived from next-generation sequencing data”, Bioinformatics, vol. 28, no. 22, pp. 2983-2985, 2012.
, “PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation”, J Infect Dis, vol. 209, no. 11, pp. 1808-15, 2014.
, “A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains”, Nat Commun, vol. 5, p. 4052, 2014.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Antimalarial therapies in children from Papua New Guinea”, N Engl J Med, vol. 360, no. 12, p. 1254; author reply 1255, 2009.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand”, Antimicrob Agents Chemother, vol. 43, no. 12, pp. 2943-9, 1999.
, “Assessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction”, Mol Biochem Parasitol, vol. 85, no. 2, pp. 161-9, 1997.
, “Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number”, Lancet, vol. 364, no. 9432, pp. 438-47, 2004.
, “World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs”, Malar J, vol. 6, p. 119, 2007.
, “Drug resistant falciparum malaria: clinical consequences and strategies for prevention”, Drug Resistance Updates, vol. 4, no. 3, pp. 187-96., 2001.
, “Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 4, pp. 547-55, 1999.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Single-dose radical cure of Plasmodium vivax: A step closer”, The Lancet, vol. 383, no. 9922, pp. 1020-1021, 2014.
, “Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis”, The Lancet Infectious Diseases, 2014.
, “Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria”, Clin Infect Dis, vol. 42, no. 11, pp. 1570-7, 2006.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 523-7, 1995.
, “Prolongation of the QTc interval in African children treated for falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, p. 503, 1998.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “A Survey of Practice and Knowledge of Refugee and Migrant Pregnant Mothers Surrounding Neonatal Jaundice on the Thailand-Myanmar Border”, J Trop Pediatr, vol. 63, no. 1, pp. 50-56, 2017.
, “Considerations on the use of nucleic acid-based amplification for malaria parasite detection”, Malar J, vol. 10, no. 1, p. 323, 2011.
, “Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria”, Tropical Medicine and International Health, vol. 6, no. 2, pp. 99-101., 2001.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant falciparum malaria in pregnancy:a preliminary report”, in 5th European Congress on Tropical Medicine and International Health, Amsterdam, the Netherlands, 2007, vol. 12, p. 34.
, “The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar”, Malar J, vol. 18, no. 1, p. 50, 2019.
, “Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody”, Nat Microbiol, vol. 4, no. 9, pp. 1497-1507, 2019.
, “Quantifying Low Birth Weight, Preterm Birth and Small-for-Gestational-Age Effects of Malaria in Pregnancy: A Population Cohort Study”, PLoS ONE, vol. 9, no. 7, p. e100247, 2014.
, “Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria”, Antimicrob Agents Chemother, vol. 55, no. 9, pp. 4338-42, 2011.
, “Effect of malaria on placental volume measured using three-dimensional ultrasound: a pilot study”, Malar J, vol. 11, no. 1, p. 5, 2012.
, “Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report”, Am J Trop Med Hyg, vol. 78, no. 4, pp. 543-5, 2008.
, “Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study”, PLoS ONE, vol. 7, no. 4, p. e34018, 2012.
, “Malaria in pregnancy in the Asia-Pacific region”, The Lancet Infectious Diseases, vol. 12, no. 1, pp. 75-88, 2012.
, “Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand”, Malar J, vol. 10, p. 113, 2011.
, “Effect of malaria in pregnancy on foetal cortical brain development: a longitudinal observational study”, Malar J, vol. 11, no. 1, p. 222, 2012.
, “Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border”, Ultrasound Obstet Gynecol, vol. 34, no. 4, pp. 395-403, 2009.
, “Malaria in pregnancy: the difficulties in measuring birthweight”, BJOG, vol. 118, no. 6, pp. 671-678, 2011.
, “Ultrasound evidence of early fetal growth restriction after maternal malaria infection”, PLoS ONE, vol. 7, no. 2, p. e31411, 2012.
, “OC08.01: Quality assessment of fetal biometry in locally trained sonographers in a developing country setting”, Ultrasound in Obstetrics & Gynecology, vol. 34, no. S1, pp. 13-13, 2009.
, “Quality of ultrasound biometry obtained by local health workers in a refugee camp on the Thai–Burmese border”, Ultrasound in Obstetrics & Gynecology, vol. 40, no. 2, pp. 151-157, 2012.
, “Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 55, no. 12, pp. 5500-6, 2011.
, “A modular framework for the development of targeted Covid-19 blood transcript profiling panels”, Journal of Translational Medicine, vol. 18, no. 1, p. 291, 2020.
, “Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119”, Vaccine, vol. 35, no. 18, pp. 2463-2472, 2017.
, “Intercontinental Spread of Pyrimethamine-Resistant Malaria”, Science, vol. 305, no. 5687, p. 1124-, 2004.
, “Stopping the Spread of Drug-Resistant Malaria”, Science, vol. 306, no. 5704, pp. 2039-40, 2004.
, “Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum”, Nat Commun, vol. 9, no. 1. p. 2317, 2018.
, “A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum”, Nat Commun, vol. 9, no. 1, p. 1837, 2018.
, “Spiroindolones, a potent compound class for the treatment of malaria”, Science, vol. 329, no. 5996, pp. 1175-80, 2010.
, “Human Plasmodium vivax diversity, population structure and evolutionary origin”, PLoS Negl Trop Dis, vol. 14, no. 3, p. e0008072, 2020.
, “Malaria epidemiology and control in refugee camps and complex emergencies”, Annals of Tropical Medicine and Parasitology, vol. 95, no. 8, pp. 741-54., 2001.
, “Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries”, JAMA, vol. 319, no. 21. pp. 2202-2211, 2018.
, “Pyronaridine-artesunate versus mefloquine plus artesunate for malaria”, N Engl J Med, vol. 366, no. 14, pp. 1298-309, 2012.
, “Human ex vivo studies on asexual Plasmodium vivax: The best way forward”, Int J Parasitol, vol. 42, no. 12, pp. 1063-70, 2012.
, “Field based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity”, Antimicrob Agents Chemother, 2013.
, “A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax”, Blood, vol. 118, no. 13, pp. 3454-3455, 2011.
, “Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis”, BMC Medicine, vol. 18, no. 1, p. 138, 2020.
, “Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis”, The Lancet Infectious Diseases, 2020.
, “Challenges to primary healthcare services in the management of non-communicable diseases in marginalised populations on the Thailand–Myanmar border: a pilot survey”, Tropical doctor, p. 0049475518786853, 2018.
, “Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs”, Lancet Child Adolesc Health, vol. 4, no. 10, pp. 761-774, 2020.
, “Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review”, Malaria Journal, vol. 16, no. 1, p. 491, 2017.
, “Optimal Duration of Follow-up for Assessing Antimalarial Efficacy in Pregnancy: A Retrospective Analysis of a Cohort Followed Up Until Delivery on the Thailand-Myanmar Border”, Open Forum Infect Dis, vol. 6, no. 7, p. ofz264, 2019.
, “Antimalarial drugs for treating and preventing malaria in pregnant and lactating women”, Expert Opin Drug Saf, vol. 17, no. 11, pp. 1129-1144, 2018.
, “Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges”, Malaria Journal, vol. 16, no. 1, p. 488, 2017.
, “Efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a protocol for systematic review and individual patient data (IPD) meta-analysis”, BMJ Open, vol. 9, no. 8, p. e027503, 2019.
, “Family planning knowledge, attitudes and practices in refugee and migrant pregnant and post-partum women on the Thailand-Myanmar border - a mixed methods study”, Reprod Health, vol. 13, no. 1, p. 94, 2016.
, “A longitudinal study of the infant nasopharyngeal microbiota: The effects of age, illness and antibiotic use in a cohort of South East Asian children”, PLoS Negl Trop Dis, vol. 11, no. 10, p. e0005975, 2017.
, “Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates”, Microbiology, vol. 158, no. Pt 6, pp. 1560-9, 2012.
, “Reagent and laboratory contamination can critically impact sequence-based microbiome analyses”, BMC Biol, vol. 12, no. 1, p. 87, 2014.
, “Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria”, Clin Pharmacol Ther, vol. 98, no. 1, pp. 87-95, 2015.
, “Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low/middle-income countries”, BMJ Open, vol. 9, no. 10, p. e026449, 2019.
, “Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri”, PLoS One, vol. 14, no. 6, p. e0217795, 2019.
, “Intrahost modeling of artemisinin resistance in Plasmodium falciparum”, Proc Natl Acad Sci U S A, vol. 108, no. 1, pp. 397-402, 2011.
, “Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias”, Malar J, vol. 17, no. 1, p. 269, 2018.
, “Detection of diverse Wolbachia 16S rRNA sequences at low titers from malaria vectors in Kayin state, Myanmar”, Wellcome Open Res, vol. 4, p. 11, 2019.
, “No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency”, Blood Cells, Molecules & Diseases, vol. 85, pp. 102484-102484, 2020.
, “Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis”, The Lancet Infectious Diseases, vol. 14, no. 8, pp. 731-741, 2014.
, “Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection”, Mol Immunol, vol. 90, pp. 158-171, 2017.
, “Plasmodium vivax trophozoites insensitive to chloroquine”, Malar J, vol. 7, no. 1, p. 94, 2008.
, “Capsular typing method for Streptococcus agalactiae using whole genome sequence data”, J Clin Microbiol, 2016.
, “Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns”, Nat Commun, vol. 10, no. 1, p. 2665, 2019.
, “Population pharmacokinetics of mefloquine in patients with acute falciparum malaria”, Clinical Pharmacology and Therapeutics, vol. 66, no. 5, pp. 472-84, 1999.
, “Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients”, PLoS Med, vol. 3, no. 11, p. e444, 2006.
, “Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum”, PLoS ONE, vol. 8, no. 7, p. e69505, 2013.
, “Interacting networks of resistance, virulence and core machinery genes identified by genome-wide epistasis analysis”, PLoS Genet, vol. 13, no. 2, p. e1006508, 2017.
, “The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density”, Nat Commun, vol. 10, no. 1, p. 1433, 2019.
, “Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison”, Lancet, vol. 367, no. 9528, pp. 2075-85, 2006.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso”, Antimicrob Agents Chemother, 2014.
, “Plasmodium vivax genetic diversity and heterozygosity in blood samples and resulting oocysts at the Thai-Myanmar border”, Malar J, vol. 16, no. 1, p. 355, 2017.
, “Empirical lessons regarding contraception in a protracted refugee setting: A descriptive study from Maela camp on the Thai-Myanmar border 1996 - 2015”, PLoS One, vol. 12, no. 2, p. e0172007, 2017.
, “Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood”, Malar J, vol. 8, p. 115, 2009.
, “Genetic diversity of three surface protein genes in Plasmodium malariae from three Asian countries”, Malar J, vol. 17, no. 1, p. 24, 2018.
, “Other 4-Methanolquinolines, Amyl Alcohols and Phentathrenes: Mefloquine, Lumefantrine and Halofantrine”, in Treatment and Prevention of Malaria, Springer Basel, 2012, pp. 95-111.
, “A tool to improve competence in the management of emergency patients by rural clinic health workers: a pilot assessment on the Thai-Myanmar border”, Confl Health, vol. 9, p. 11, 2015.
, “In vivo parasitological measures of artemisinin susceptibility”, J Infect Dis, vol. 201, no. 4, pp. 570-9, 2010.
, “In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up”, Antimicrob Agents Chemother, vol. 48, no. 11, pp. 4271-80, 2004.
, “Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach”, Malar J, vol. 6, no. 1, p. 4, 2007.
, “Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity”, Malar J, vol. 7, no. 1, p. 249, 2008.
, “Folate supplementation to prevent birth abnormalities: evaluating a community-based participatory action plan for refugees and migrant workers on the Thailand-Myanmar border”, Public Health, vol. 161, pp. 83-89, 2018.
, “International estimated fetal weight standards of the INTERGROWTH-21st Project”, Ultrasound Obstet Gynecol, vol. 49, no. 4, pp. 478-486, 2017.
, “Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data”, The Lancet Infectious Diseases, 2020.
, “Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis”, Malar J, vol. 18, no. 1, p. 225, 2019.
, “Impact of Food Rations and Supplements on Micronutrient Status by Trimester of Pregnancy: Cross-Sectional Studies in the Maela Refugee Camp in Thailand”, Nutrients, vol. 8, no. 2, p. 66, 2016.
, “Relation of DDT residues to plasma retinol, a-tocopherol, and ฿-carotene during pregnancy and malaria infection: A case–control study in Karen women in northern Thailand”, Science of The Total Environment, vol. 363, no. 1-3, pp. 78-86, 2005.
, “Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp”, Eur J Nutr, vol. 51, no. 4, pp. 425-34, 2012.
, “Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally”, J Infect Dis, vol. 201, no. 10, pp. 1544-50, 2010.
, “Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance”, J Antimicrob Chemother, vol. 70, no. 1, pp. 124-9, 2015.
, “Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms”, PLoS ONE, vol. 2, no. 10, p. e1089, 2007.
, “Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax”, J Infect Dis, vol. 198, no. 10, pp. 1558-64, 2008.
, “Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia”, J Infect Dis, vol. 211, no. 5, pp. 670-9, 2015.
, “Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia”, Proc Natl Acad Sci U S A, vol. 110, no. 1, pp. 240-5, 2013.
, “Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border”, Malar J, vol. 7, p. 209, 2008.
, ““Nine Dimensions”: A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, Myanmar”, Wellcome Open Research, vol. 3, 2018.
, “"Nine Dimensions": A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, Myanmar [version 2; peer review: 2 approved]”, Wellcome Open Research, vol. 3, no. 116, p. 116, 2019.
, “"Nine Dimensions": A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, Myanmar”, Wellcome Open Res, vol. 3, p. 116, 2018.
, “Genetic Variability of Plasmodium malariae dihydropteroate synthase (dhps) in Four Asian Countries”, PLoS ONE, vol. 9, no. 4, p. e93942, 2014.
, “Genetic Marker Suitable for Identification and Genotyping of Plasmodium ovale curtisi and Plasmodium ovale wallikeri”, J Clin Microbiol, vol. 51, no. 12, pp. 4213-6, 2013.
, “Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria”, Antimicrob Agents Chemother, vol. 53, no. 9, pp. 3837-46, 2009.
, “Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda”, Antimicrob Agents Chemother, vol. 57, no. 10, pp. 5096-103, 2013.
, “Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand”, Antimicrob Agents Chemother, vol. 52, no. 3, pp. 1052-61, 2008.
, “Population Pharmacokinetics and Pharmacodynamics of Piperaquine in Children With Uncomplicated Falciparum Malaria”, CLIN PHARMACOL THER, vol. 91, no. 3, pp. 497-505, 2012.
, “Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda”, Malar J, vol. 11, no. 1, p. 293, 2012.
, “Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand”, CPT: pharmacomet. syst. pharmacol., vol. 3, p. e132, 2014.
, “Population pharmacokinetics of antimalarial drugs in the treatment of pregnant women with uncomplicated malaria”, in 59th Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, USA, 2010, vol. 83, p. 2.
, “Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria”, Antimicrob Agents Chemother, vol. 56, no. 4, pp. 1997-2007, 2012.
, “Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy”, Antimicrob Agents Chemother, vol. 56, no. 11, pp. 5764-5773, 2012.
, “Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria”, Antimicrob Agents Chemother, vol. 58, no. 4, pp. 2052-2058, 2014.
, “Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent”, PLoS Genet, vol. 13, no. 10, p. e1007065, 2017.
, “Resolving the cause of recurrent Plasmodium vivax malaria probabilistically”, Nat Commun, vol. 10, no. 1, p. 5595, 2019.
, “Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay”, British Journal of Clinical Pharmacology, vol. 42, no. 5, pp. 599-604, 1996.
, “Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border”, Malar J, vol. 12, p. 275, 2013.
, “Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir”, Malar J, vol. 14, p. 86, 2015.
, “Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014”, Int J Tuberc Lung Dis, vol. 21, no. 7, pp. 753-758, 2017.
, “Neonatal Hyperbilirubinemia in a Marginalized Population on the Thai-Myanmar Border: a study protocol”, BMC Pediatr, vol. 17, no. 1, p. 32, 2017.
, “Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014”, BMC pediatrics, vol. 18, no. 1, p. 190, 2018.
, “Laboratory validation and field usability assessment of a point-of-care test for serum bilirubin levels in neonates in a tropical setting”, Wellcome Open Res, vol. 3. p. 110, 2018.
, “Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study”, Wellcome Open Res, vol. 3, p. 1, 2018.
, “The chromosomal organization of the Plasmodium falciparum var gene family is conserved”, Mol Biochem Parasitol, vol. 87, no. 1, pp. 49-60, 1997.
, , “Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates”, Malar J, vol. 18, no. 1, p. 295, 2019.
, “Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru”, Malaria journal, vol. 17, no. 1, p. 339, 2018.
, “Estimation of the in-vivo minimum inhibitory concentration of cipargamin in uncomplicated Plasmodium falciparum malaria”, Antimicrob Agents Chemother, 2016.
, “High-resolution single-cell sequencing of malaria parasites”, bioRxiv, 2017.
, “Migrant tuberculosis patient needs and health system response along the Thailand-Myanmar border”, Health Policy Plan, vol. 32, no. 8, pp. 1212-1219, 2017.
, “Choosing where to give birth: Factors influencing migrant women's decision making in two regions of Thailand”, PLoS One, vol. 15, no. 4, p. e0230407, 2020.
, “Migrant and Refugee Patient Perspectives on Travel and Tuberculosis along the Thailand-Myanmar Border: A Qualitative Study”, PLoS One, vol. 11, no. 8, p. e0160222, 2016.
, “Treating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar border”, BMC Health Serv Res, vol. 17, no. 1, p. 29, 2017.
, “Access to free or low-cost tuberculosis treatment for migrants and refugees along the Thailand-Myanmar border in Tak province, Thailand”, Int J Equity Health, vol. 15, no. 1, p. 100, 2016.
, “Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker”, Lancet Infect Dis, vol. 15, no. 4, pp. 415-21, 2015.
, “A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border”, BMC Infect Dis, vol. 13, p. 601, 2013.
, “Neonatal intensive care in a karen refugee camp: a 4 year descriptive study”, PLoS ONE, vol. 8, no. 8, p. e72721, 2013.
, “A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage”, BMC Infect Dis, vol. 11, p. 108, 2011.
, “The epidemiology of pneumonia in a birth cohort of children living on the Thai-Myanmar border”, INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 16, pp. E13-E13, 2012.
, “Rectal pH in Well and Unwell Infants”, J Trop Pediatr, vol. 59, no. 2, p. 162, 2013.
, “Field evaluation of culture plus latex sweep serotyping for detection of multiple pneumococcal serotype colonisation in infants and young children”, PLoS ONE, vol. 8, no. 7, p. e67933, 2013.
, “Aeromonas spp. Bacteremia in Pregnant Women, Thailand-Myanmar Border, 2011”, Emerg Infect Dis, vol. 18, no. 9, pp. 1522-3, 2012.
, “ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance”, Wellcome Open Res, vol. 5, p. 13, 2020.
, “Changes in the body weight of term infants, born in the tropics, during the first seven days of life”, BMC Pediatr, vol. 13, no. 1, p. 93, 2013.
, “Detection of respiratory viruses by PCR of nasopharyngeal swabs stored in STGG transport medium”, J. Clin. Microbiol., vol. 49, no. 6, pp. 2311-2313, 2011.
, “Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border”, BMC Infectious Diseases, vol. 12, no. 1, p. 34, 2012.
, “Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother–infant pairs on the Thailand–Burma border”, Clinical Microbiology and Infection, vol. 18, no. 10, pp. 970-975, 2012.
, “Influenza in refugees on the Thailand-Myanmar border, May-October 2009”, Emerg Infect Dis, vol. 16, no. 9, pp. 1366-72, 2010.
, “A High Burden of Respiratory Syncytial Virus Associated Pneumonia in Children Less than Two Years of Age in a South East Asian Refugee Population”, PLoS ONE, vol. 7, no. 11, p. e50100, 2012.
, “High rates of pneumonia in children under two years of age in a South East Asian refugee population”, PLoS ONE, vol. 8, no. 1, p. e54026, 2013.
, “Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border”, BMC Infectious Diseases, vol. 13, no. 1, p. 434, 2013.
, “A Longitudinal Study of Streptococcus pneumoniae Carriage in a Cohort of Infants and Their Mothers on the Thailand-Myanmar Border”, PLoS ONE, vol. 7, no. 5, p. e38271, 2012.
, “Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand”, J Infect Dis, vol. 195, no. 1, pp. 134-41, 2007.
, “A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants”, Malar J, vol. 17, no. 1. p. 175, 2018.
, “An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia”, PLoS ONE, vol. 5, no. 7, p. e11880, 2010.
, “Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh”, Trop Med Int Health, vol. 9, no. 6, pp. 680-7, 2004.
, “Efficacy of chloroquine + sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh”, Trans R Soc Trop Med Hyg, 2005.
, “Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 936-42, 1999.
, “The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 564-5, 1998.
, “The treatment of chloroquine-resistant malaria”, Tropical Doctor, vol. 29, no. 3, pp. 176-9, 1999.
, “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545-8., 2000.
, “Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria”, Antimicrob Agents Chemother, vol. 42, no. 1, pp. 135-9, 1998.
, “Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil”, Clinical Infectious Diseases, vol. 35, no. 12, pp. 1498-504., 2002.
, “No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 61, no. 6, pp. 964-7, 1999.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Absence of an interaction between artesunate and atovaquone-proguanil”, European Journal of Clinical Pharmacology, vol. 55, no. 6, pp. 469-74, 1999.
, “US Immigration Westernizes the Human Gut Microbiome”, Cell, vol. 175, no. 4, pp. 962-972 e10, 2018.
, “Plasmodium falciparum genetic crosses in a humanized mouse model”, Nat Methods, vol. 12, no. 7, pp. 631-3, 2015.
, “Complex polymorphisms in the Plasmodium falciparum Multidrug Resistance Protein 2 gene and its contribution to antimalarial response”, Antimicrob Agents Chemother, vol. 58, no. 12, pp. 7390-7397, 2014.
, “pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine”, Antimicrob Agents Chemother, vol. 56, no. 7, pp. 3615-9, 2012.
, “Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance”, PLoS ONE, vol. 6, no. 5, p. e20212, 2011.
, “Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine”, Am J Trop Med Hyg, vol. 91, no. 4, pp. 833-43, 2014.
, “The effect of varying analytical methods on estimates of anti-malarial clinical efficacy”, Malar J, vol. 8, p. 77, 2009.
, “Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast”, Infect Immun, vol. 82, no. 3, pp. 1296-1307, 2014.
, “Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial”, Trop Med Int Health, vol. 12, no. 2, pp. 209-18, 2007.
, “The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos”, Malar J, vol. 18, no. 1, p. 449, 2019.
, “The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial”, PLoS Med, vol. 16, no. 2, p. e1002745, 2019.
, , “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Intracranial pressure in childhood cerebral malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 362-4, 1991.
, “Multiple displacement amplification for malaria parasite DNA”, J Parasitol, vol. 95, no. 1, pp. 253-5, 2009.
, “Single dose pharmacokinetics of proguanil and its metabolites in pregnancy”, European Journal of Clinical Pharmacology, vol. 44, no. 3, pp. 247-51, 1993.
, “Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance”, Lancet Infect Dis, vol. 7, no. 2, pp. 136-44, 2007.
, “Characterising blood stage antimalarial drug minimum inhibitory concentrations in vivo using reinfection patterns”, Antimicrobial agents and chemotherapy, pp. AAC. 02476-17, 2018.
, “Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria”, PLoS neglected tropical diseases, vol. 12, no. 4, p. e0006440, 2018.
, “A Prospective Evaluation of Real-Time PCR Assays for the Detection of Orientia tsutsugamushi and Rickettsia spp. for Early Diagnosis of Rickettsial Infections during the Acute Phase of Undifferentiated Febrile Illness”, Am J Trop Med Hyg, 2013.
, “Scrub typhus infection in pregnancy: the dilemma of diagnosis and treatment in a resource-limited setting”, Clinical Case Reports, p. n/a-n/a, 2016.
, “A prospective evaluation of diagnostic methodologies for the acute diagnosis of dengue virus infection on the Thailand-Myanmar border”, Trans R Soc Trop Med Hyg, vol. 105, no. 1, pp. 32-7, 2011.
, “Diagnostic Accuracy Assessment of Immunochromatographic Tests for the Rapid Detection of Antibodies Against Orientia tsutsugamushi Using Paired Acute and Convalescent Specimens”, Am J Trop Med Hyg, vol. 93, no. 6, pp. 1168-71, 2015.
, “Evaluation of a surgical service in the chronic phase of a refugee camp: an example from the Thai-Myanmar border”, Conflict and Health, vol. 6, no. 1, p. 5, 2012.
, “WHO, the Global Fund, and medical malpractice in malaria treatment”, Lancet, vol. 363, no. 9415, p. 1160, 2004.
, “New Medicines for Tropical Diseases in Pregnancy: Catch-22”, PLoS Medicine, vol. 5, no. 6, p. e133, 2008.
, “Spiroindolone KAE609 for falciparum and vivax malaria”, N Engl J Med, vol. 371, no. 5, pp. 403-10, 2014.
, “Accelerated Training of Skilled Birth Attendants in a Marginalized Population on the Thai-Myanmar Border: A Multiple Methods Program Evaluation”, PLoS One, vol. 11, no. 10, p. e0164363, 2016.
, “Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria”, N Engl J Med, vol. 375, no. 12, pp. 1152-60, 2016.
, “Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine”, Clin Pharmacokinet, vol. 37, no. 2, pp. 105-25., 1999.
, “Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria”, Malar J, vol. 13, no. 1, p. 483, 2014.
, “Estimation of gestational age from fundal height: a solution for resource-poor settings”, J R Soc Interface, vol. 9, no. 68, pp. 503-510, 2012.
, “Averting a malaria disaster”, The Lancet, vol. 353, no. 9168, pp. 1965-1967, 1999.
, “Toxic brainstem encephalopathy after artemisinin treatment for breast cancer”, Ann Neurol, vol. 59, no. 4, pp. 725-6, 2006.
, “Comparison of artemether and chloroquine for severe malaria in Gambian children”, Lancet, vol. 339, pp. 317-21, 1992.
, “High initiation and long duration of breastfeeding despite absence of early skin-to-skin contact in Karen refugees on the Thai-Myanmar border: a mixed methods study”, Int Breastfeed J, vol. 7, no. 1, p. 19, 2012.
, “Averting a malaria disaster (reply)”, The Lancet, vol. 354, no. 9187, pp. 1389-1390, 1999.
, “Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach”, PLoS Med, vol. 12, no. 4, p. e1001823, 2015.
, “Artesunate versus quinine for severe falciparum malaria - Authors' reply”, Lancet, vol. 367, no. 9505, pp. 111-112, 2006.
, “Melioidosis in Myanmar”, Trop Med Infect Dis, vol. 3, no. 1, 2018.
, “Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions”, J Clin Microbiol, vol. 53, no. 10, pp. 3296-303, 2015.
, “High-throughput analysis of antimalarial susceptibility data by the WWARN In Vitro Analysis and Reporting Tool (IVART)”, Antimicrob Agents Chemother, 2013.
, “Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort”, BMJ Paediatrics Open, vol. 4, no. 1, p. e000641, 2020.
, “Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia”, Genome Med, vol. 12, no. 1, p. 11, 2020.
, “Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border”, Am J Trop Med Hyg, vol. 99, no. 2, pp. 350-356, 2018.
, “Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border”, J Infect Dis, vol. 215, no. 3, pp. 396-404, 2017.
, “Therapeutic disruption of Plasmodium vivax infected red cell deformability”, Malaria Journal, vol. 13, no. Suppl 1, p. O25, 2014.
, “A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609”, J Infect Dis, vol. 213, no. 1, pp. 100-4, 2016.
, “Rheopathologic Consequence of Plasmodium vivax Rosette Formation”, PLoS Negl Trop Dis, vol. 10, no. 8, p. e0004912, 2016.
, “New insights into the Plasmodium vivax transcriptome using RNA-Seq”, Sci Rep, vol. 6, p. 20498, 2016.
, “The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background”, Nat Commun, vol. 9, no. 1, p. 5158, 2018.
, “Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine”, PLoS One, vol. 9, no. 8, p. e103200, 2014.
, “Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso”, Antimicrobial Agents and Chemotherapy, vol. 59, no. 8, pp. 4387-4396, 2015.
, “Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis”, Malar J, vol. 8, p. 203, 2009.
, “Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis”, PLoS ONE, vol. 4, no. 7, p. e6358, 2009.
, “Efficacy of artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated falciparum malaria in sub-Saharan Africa: An individual patient data meta analysis (IPDM) in 3,455 patients”, in 56th Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, USA, 2007, vol. 77, p. 287.
,